ab54837 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab54837 は 7 報の論文で使用されています。

  • Chen M  et al. Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasion. PLoS One 9:e89892 (2014). Human . PubMed: 24587105
  • Passadouro M  et al. MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer. Int J Nanomedicine 9:3203-17 (2014). WB . PubMed: 25061297
  • Tripathi V  et al. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion. Oncogene N/A:N/A (2013). PubMed: 23376848
  • Del Galdo S  et al. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis. Cell Signal 25:2478-84 (2013). PubMed: 23993968
  • Klopp AH  et al. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 5: (2010). WB ; Human . PubMed: 20808935
  • Quinn K  et al. Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol 83:10176-86 (2009). WB, ICC/IF ; Human . PubMed: 19625394
  • Murray D  et al. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer 99:1322-9 (2008). WB ; Human . PubMed: 18827818

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"